Literature DB >> 36066831

Motoneuron Diseases.

Francesco Lotti1, Serge Przedborski2.   

Abstract

Motoneuron diseases (MNDs) represent a heterogeneous group of progressive paralytic disorders, mainly characterized by the loss of upper (corticospinal) motoneurons, lower (spinal) motoneurons or, often both. MNDs can occur from birth to adulthood and have a highly variable clinical presentation, even within gene-positive forms, suggesting the existence of environmental and genetic modifiers. A combination of cell autonomous and non-cell autonomous mechanisms contributes to motoneuron degeneration in MNDs, suggesting multifactorial pathogenic processes.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; C9ORF72; Cell autonomy; FUS; Motoneuron diseases; Motor cortex; Neurodegeneration; Spinal cord; Spinal muscular atrophy; Superoxide dismutase-1; TDP43

Mesh:

Substances:

Year:  2022        PMID: 36066831     DOI: 10.1007/978-3-031-07167-6_13

Source DB:  PubMed          Journal:  Adv Neurobiol


  175 in total

1.  CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS.

Authors:  David R Beers; Jenny S Henkel; Weihua Zhao; Jinghong Wang; Stanley H Appel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

2.  Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.

Authors:  David R Beers; Jenny S Henkel; Qin Xiao; Weihua Zhao; Jinghong Wang; Albert A Yen; Laszlo Siklos; Scott R McKercher; Stanley H Appel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

3.  Phase separation in biology.

Authors:  Simon Alberti
Journal:  Curr Biol       Date:  2017-10-23       Impact factor: 10.834

Review 4.  Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease?

Authors:  Elena Abati; Gaia Citterio; Nereo Bresolin; Giacomo P Comi; Stefania Corti
Journal:  Neurobiol Dis       Date:  2020-04-12       Impact factor: 5.996

5.  An estimate of amyotrophic lateral sclerosis heritability using twin data.

Authors:  A Al-Chalabi; F Fang; M F Hanby; P N Leigh; C E Shaw; W Ye; F Rijsdijk
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-22       Impact factor: 13.654

Review 6.  Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies.

Authors:  David R Beers; Stanley H Appel
Journal:  Lancet Neurol       Date:  2019-02       Impact factor: 44.182

7.  Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity.

Authors:  Alice Brockington; Ke Ning; Paul R Heath; Elizabeth Wood; Janine Kirby; Nicolò Fusi; Neil Lawrence; Stephen B Wharton; Paul G Ince; Pamela J Shaw
Journal:  Acta Neuropathol       Date:  2012-11-13       Impact factor: 17.088

8.  Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.

Authors:  David R Beers; Jenny S Henkel; Weihua Zhao; Jinghong Wang; Ailing Huang; Shixiang Wen; Bing Liao; Stanley H Appel
Journal:  Brain       Date:  2011-05       Impact factor: 13.501

9.  Complement activation at the motor end-plates in amyotrophic lateral sclerosis.

Authors:  Nawal Bahia El Idrissi; Sanne Bosch; Valeria Ramaglia; Eleonora Aronica; Frank Baas; Dirk Troost
Journal:  J Neuroinflammation       Date:  2016-04-07       Impact factor: 8.322

10.  Relaxation of synaptic inhibitory events as a compensatory mechanism in fetal SOD spinal motor networks.

Authors:  Pascal Branchereau; Elodie Martin; Anne-Emilie Allain; William Cazenave; Laura Supiot; Fara Hodeib; Amandine Laupénie; Urvashi Dalvi; Hongmei Zhu; Daniel Cattaert
Journal:  Elife       Date:  2019-12-23       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.